Skip to main content
All lobbying filings

Buchanan Ingersoll & Rooney PC

Buchanan Ingersoll & Rooney PC filed a Q4 report for Bright Path Labs on January 20, 2026, reporting $30,000 in lobbying income.

Lobbying for Bright Path Labs · Pharmaceutical company

As filed: BUCHANAN INGERSOLL & ROONEY PC for BRIGHT PATH LABS.

All filings by Buchanan Ingersoll & Rooney PC · Everything Bright Path Labs has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$30,000
What the client paid this registrant for the period.
Client based in
North Carolina

Official filing document

 Lobbyists on this filing 1
  • AMANDA LINCOLN
    Previously held: Staff Director, Senate Health, Education, Labor, and Pensions Committee; Legislative Director, Sen. Mike Enzi; Health Policy Director, Sen. Susan Collins

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 6

Develop and execute a government relations strategy on issues relevant to Bright Path Labs.

Develop and execute a government relations strategy on issues relevant to Bright Path Labs.

Develop and execute a government relations strategy on issues relevant to Bright Path Labs.

Develop and execute a government relations strategy on issues relevant to Bright Path Labs.

Develop and execute a government relations strategy on issues relevant to Bright Path Labs.

Develop and execute a government relations strategy on issues relevant to Bright Path Labs.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem